UK Device, IVD Sector Cheered By New Funding Pledge For Accelerated Access Program
Executive Summary
UK Government health minister James O'Shaughnessy has delighted local medtech innovators with the promise of a package of funding under the Accelerated Access Review (AAR).
You may also be interested in...
NHS Medtech Demand-Side Should Be Greater Priority, Says UK Industry In AAR Response
The Accelerated Access Review, part of the UK's renewed push to speed access to innovations for system efficiency, cost savings and outcomes improvements, strikes most of the right notes, but there is still room for improvement in the framework of innovation adoption by the NHS, according to an industry-commissioned response to the review.
UK Viewpoint: AHSNs, AAR And Accelerators – Market Access & Innovation Update
Dr Charlie Davie, managing director of UCLPartners, a London-based Academic Health Science Partnership and one of the 15 UK Academic Health Science Networks, updates Medtech Insight on key changes in NHS market access policy this summer.
Brexit Health Alliance Adds To UK-EU Debate; Medtechs Settle Into Interim Brexit Pace
The pace of Brexit-related work that impacts the UK medtech industry shows no sign of slowing over the summer. In view of unexpected – uncomfortable for some – recent opinion poll findings, there is unlikely to be a significant change in somewhat febrile UK atmosphere anytime soon. And the future UK medtech regulatory situation still needs close attention.